Cite
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities
MLA
Cynthia Osborne, et al. “Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities.” Molecular Cancer Therapeutics, vol. 12, no. 1, Nov. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5b67730b826b82d8d910de6cb39d5d9&authtype=sso&custid=ns315887.
APA
Cynthia Osborne, Shripad Sinari, Cristi L Aitelli, Tracy M. Moses, Angela Baker, Jennifer Dinh, Bodour Salhia, Joanne L. Blum, Ahmet Kurdoglu, Julie Koeman, Jessica Aldrich, Catalin Barbacioru, Jeff Kiefer, Spyro Mousses, David Craig, John D. Carpten, Jeffrey M. Trent, Alexis Christoforides, Onur Sakarya, … Paul Billings. (2012). Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Molecular Cancer Therapeutics, 12(1).
Chicago
Cynthia Osborne, Shripad Sinari, Cristi L Aitelli, Tracy M. Moses, Angela Baker, Jennifer Dinh, Bodour Salhia, et al. 2012. “Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities.” Molecular Cancer Therapeutics 12 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5b67730b826b82d8d910de6cb39d5d9&authtype=sso&custid=ns315887.